openPR Logo
Press release

Global Market for Influenza Antiviral to Witness Considerable Upsurge During 2018 - 2028

09-20-2018 12:24 PM CET | Health & Medicine

Press release from: Future Market Insights

Global Market for Influenza Antiviral to Witness Considerable

Influenza is a viral disease having the same symptoms as most of the flus, such as fever, chills, cough, pain, sore throat, etc. Influenza antiviral drugs make the most effective and safe treatment option for this flu and are available in the form of pills, inhalers, oral suspension and injectables. These drugs are sold only with a prescription and are not available over the counter. Influenza antiviral drugs make flu symptoms milder and reduce the duration of illness. However, they do not eliminate the risk of complications, which include bacterial infections, pneumonia, organ system abnormalities, etc. Oseltamivir, Zanamivir and Peramivir are the most preferred drugs, which are effective against both influenza A and B viruses. These commercially approved influenza antiviral drugs also have several side effects, such as nausea, vomiting, diarrhoea and certain behavioural changes. The drugs are available to be used for children, adults as well as old people.
Request For Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7031

Influenza outbreaks usually happen every year and may reach epidemic levels during some seasons. Influenza antiviral drugs create a huge healthcare burden globally each year. According to CDC, there have been between 9.2 million and 35.6 million cases, between 140,000 and 710,000 hospitalization cases and between 12,000 and 56,000 deaths annually, since 2010, in the U.S.

Influenza Antiviral Market: Drivers & Restraints

Ongoing R&D, increasing demand for government stockpiling and strong R&D focus will fuel the growth of the influenza antiviral drugs market. Launching of generic versions of branded products will also promote the growth of the influenza antiviral market. For instance, the generic version of Tamiflu antiviral drug was released in 2016 and has affected the Influenza Antiviral Market positively. Adoption of influenza vaccination is also a restraint to the growth of the influenza antiviral market. Unmet medical needs in certain global regions will also limit the market growth of the influenza antiviral market.

Influenza Antiviral Market: Segmentation

The Influenza Antiviral Market can be segmented on the basis of drug type, dosage form and distribution channel.

Segmentation of Influenza Antiviral Marketby Drug Type

Oseltamivir
Zanamivir
Peramivir
Adamantanes
Other
Segmentation of Influenza Antiviral Marketby Dosage Form

Oral
Inhalation
Intravenous
Segmentation of Influenza Antiviral Marketby Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Influenza Antiviral Market: Overview

Mergers and collaborations among the market players for R&D, product manufacturing and marketing will play an important role in the growth of theInfluenza Antiviral Market. Influenza is a seasonal outbreak and thus, the market for its drugs is also expected to grow during the outbreaks. Currently marketed influenza antiviral medications are approximately 70% to 90% effective in preventing influenza. Several studies for the available drugs have also proved their efficacy in children as well as adults. According to CDC, there are currently no major market shortages of influenza antiviral medications. Resistance associated with the currently marketed drugs might generate the need for the development of novel medications. Also, there exists variations in the working of antiviral drugs, depending on the influenza strain of influenza. Several new findings are still going on to develop safe and effective influenza antiviral drugs. New drugs are anticipated to get approved and marketed in the next few years, which will provide physicians with more options for the treatment and prevention of the disease.

Influenza Antiviral Market: Region-wise Outlook

Geographically, North America holds the largest share in the influenza antiviral market owing to the high prevalence of influenza in the region and the favorable reimbursement scenario in the region. North America is followed by the Western Europe market due to easy access to healthcare facilities and governmental support for the control on the spread of contagious diseases. The Asia-Pacific market is also anticipated to expand at a significant growth rate over the forecast period due to the improving healthcare facilities and increasing accessibility to disease diagnosis. China and India are the countries with highest growth rate in the region. Latin America followed by MEA represents the lowest market share due to inaccessibility to healthcare facilities in the region. However, various kinds of governmental and non-governmental support is available in the region, which will drive the growth of the market.

Request For Report Table of Content (TOC): https://www.futuremarketinsights.com/toc/rep-gb-7031

Influenza Antiviral Market: Key Players

Some of the market participants identified across the value chain of the Influenza Antiviral market are F. Hoffmann-La Roche Ltd., Cipla Limited, NATCO Pharma Limited, Seqirus USA Inc., GlaxoSmithKline Pharmaceuticals Ltd, Endo Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Adamas Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG and others.

About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Market for Influenza Antiviral to Witness Considerable Upsurge During 2018 - 2028 here

News-ID: 1251296 • Views:

More Releases from Future Market Insights

Aerospace Fluid Conveyance System Market to Reach USD 4.3 Billion by 2035 with Innovative Components and Growth
Aerospace Fluid Conveyance System Market to Reach USD 4.3 Billion by 2035 with I …
The global Aerospace Fluid Conveyance System Market is witnessing steady growth, driven by the increasing demand for advanced fluid handling solutions across commercial and military aircraft. Valued at USD 3.1 billion in 2025, the market is projected to reach USD 4.3 billion by 2035, registering a healthy CAGR of 3.4%. Both established and emerging manufacturers are actively innovating to meet the evolving needs of the aviation sector. Market Dynamics and Growth
Automotive Starter and Alternator Market to Reach USD 45.4 Billion by 2035 Amid Electrification Trends
Automotive Starter and Alternator Market to Reach USD 45.4 Billion by 2035 Amid …
The global Automotive Starter and Alternator Market is on track for substantial expansion, driven by rapid advancements in vehicle technology and the growing focus on electrification. Valued at USD 29.3 billion in 2025, the market is projected to reach USD 45.4 billion by 2035, registering a CAGR of 4.5% during the forecast period. The growth reflects the automotive industry's continuous evolution toward fuel-efficient and sustainable systems that integrate reliability, performance,
Connected Aircraft Market Soars to USD 63.6 Billion by 2035, Driven by Connectivity and Digital Innovation
Connected Aircraft Market Soars to USD 63.6 Billion by 2035, Driven by Connectiv …
The global Connected Aircraft Market is poised for transformative growth, projected to rise from USD 6.8 billion in 2025 to USD 63.6 billion by 2035, registering an impressive CAGR of 25.1% over the forecast period. This surge is being fueled by airlines' growing focus on enhancing operational efficiency, passenger experience, and safety through advanced connectivity solutions. Industry leaders such as Honeywell International Inc., Thales Group, Raytheon Technologies Corporation, BAE Systems PLC,
Slingshot/3-Wheeled Motorcycle Market Set to Hit USD 1.8 Billion by 2035 Driven by Design and Innovation
Slingshot/3-Wheeled Motorcycle Market Set to Hit USD 1.8 Billion by 2035 Driven …
The global Slingshot/3-Wheeled Motorcycle Market is on track to witness sustained growth, driven by shifting consumer lifestyles, urban mobility trends, and a rising interest in alternative transportation. Valued at USD 1.3 billion in 2025, the market is projected to reach USD 1.8 billion by 2035, expanding at a CAGR of 2.9%. During the early growth phase (2021-2025), the market experiences gradual expansion, fueled by consumers' growing appetite for distinctive vehicles that

All 5 Releases


More Releases for Influenza

Multivalent Influenza Vaccines Market Advancing Influenza Prevention Strategies …
The "Multivalent Influenza Vaccines Market" research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Multivalent Influenza Vaccines industry along with various other factors over the predicted period 2024-2030. The report on the Multivalent Influenza Vaccines market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels, profit margin, etc.
Influenza Diagnostics Market - Rapid Detection, Effective Protection: Influenza …
Newark, New Castle, USA: The "Influenza Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Influenza Diagnostics Market: https://www.growthplusreports.com/report/influenza-diagnostics-market/8780 This latest report researches the industry structure, sales, revenue,
Influenza Medication Market - Fight off the influenza virus with effective and r …
Newark, New Castle, USA: The "Influenza Medication Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Influenza Medication Market: https://www.growthplusreports.com/report/influenza-medication-market/7859 This latest report researches the industry structure, sales, revenue,
Influenza Medication Market - Revolutionizing Flu Treatment: Innovating Advanced …
Newark, New Castle, USA - new report, titled Influenza Medication Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Medication market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Medication market. The report offers an overview of the market, which
Influenza Vaccines Market - Empowering Strength, Nurturing Immunity: Innovating …
Newark, New Castle, USA - new report, titled Influenza Vaccines Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Vaccines market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Vaccines market. The report offers an overview of the market, which
H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,